Logo image
Type 2 diabetes mellitus, brain atrophy, and cognitive decline
Journal article   Open access   Peer reviewed

Type 2 diabetes mellitus, brain atrophy, and cognitive decline

Chris Moran, Richard Beare, Wei Wang, Michele Callisaya, Velandai Srikanth and Alzheimer's Disease Neuroimaging Initiative (ADNI)
Neurology, Vol.92(8), pp.e823-e830
02/19/2019
DOI: 10.1212/WNL.0000000000006955
PMCID: PMC7987953
PMID: 30674592
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7987953View
Open Access

Abstract

To study longitudinal relationships between type 2 diabetes mellitus (T2DM), cortical thickness, and cognitive function in older people with normal cognition, mild cognitive impairment, and Alzheimer disease (AD). The sample was derived from the Alzheimer's Disease Neuroimaging Initiative cohort who underwent brain MRI and cognitive tests annually for 5 years. Presence of T2DM was based on fasting blood glucose ≥7.0mml/L or the use of glucose-lowering agents. We used latent growth curve modeling to explore longitudinal relationships between T2DM, cortical thickness, and cognitive function, adjusting for relevant covariates and testing for interactions. There were 124 people with T2DM (mean age 75.5 years, SD 6.2) and 693 without T2DM (mean age 75.1 years, SD 6.9) with at least 1 MRI available. AD and lower cortical thickness at study entry was associated with a lower chance of having a MRI available at each follow-up phase (all < 0.001). T2DM was associated with lower baseline cortical thickness ( = 0.01). We found no direct effect of T2DM on decline in cortical thickness or cognitive function, but there was an indirect pathway linking T2DM and cognitive decline via baseline cortical thickness (β = -0.17, = 0.022). There was an interaction between T2DM and education whereby the negative effect of T2DM on baseline cortical thickness was reduced in those with greater education (β = 0.34, = 0.037). These associations changed minimally when adjusted for baseline cognitive diagnosis. In an older cohort with low cerebrovascular disease burden, T2DM contributes to cognitive decline via neurodegeneration. Prior brain and cognitive reserve may protect against this effect.
Magnetic Resonance Imaging Brain - diagnostic imaging Humans Cerebral Cortex - pathology Organ Size Male Factor Analysis, Statistical Diabetes Mellitus, Type 2 - metabolism Cerebral Cortex - diagnostic imaging Diabetes Mellitus, Type 2 - epidemiology Atrophy - epidemiology Cognitive Dysfunction - epidemiology Aged, 80 and over Brain - pathology Alzheimer Disease - epidemiology Female Aged Alzheimer Disease - diagnostic imaging Blood Glucose - metabolism Cognitive Dysfunction - diagnostic imaging Longitudinal Studies

Details

Logo image